Navigation Links
Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
Date:12/3/2008

registration trial, 20% if OGX-011 is licensed prior to marketing approval and 15% thereafter. In addition, Isis currently owns approximately 2% of the outstanding common stock of OncoGenex.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 19 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ibis Biosciences, Inc., Isis' majority-owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at www.isispharm.com.

This press release includes forward-looking statements regarding Isis' business, its drug discovery and development pipeline, and the therapeutic potential of OGX-011 for the treatment of cancer. Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Isis' goals. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ewswire/ -- Breast-Specific Gamma Imaging (BSGI) h...chnique for the detection of ductal carcinoma in s... BSGI is a molecular breast imaging technique that... discover very early stage cancers. According to f...he Radiological Society of North America (RSNA), B...
(Date:11/30/2009)...Newswire/ -- Breast-Specific Gamma Imaging (BSGI) ...gnant or high-risk lesions in patients with negati...ng to results of a multicenter study presented tod...ty of North America (RSNA). ,, In this retrospe...nostic imaging modality at four institutions and w...
(Date:11/30/2009)...v. 30 Covance Inc. (NYSE...the Piper Jaffray 21st Annual Health Care Conferen...). Investors may access a live webcast of the pre...ter and download any necessary software, please lo...rters in Princeton, New Jersey, is one of the worl...
Breaking Medicine Technology:Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings 2The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide 4568 1The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide 4568 2The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide 4568 3Breast feeding OK for Most Moms with MS 48225 1Breast feeding OK for Most Moms with MS 48225 2Breast feeding OK for Most Moms with MS 48225 3Lack of Sleep Can Raise Blood Pressure Over Time 48223 1Lack of Sleep Can Raise Blood Pressure Over Time 48223 2
...tein Institute for Medical Research have identifie...or rheumatoid arthritis and systemic lupus,erythem...diseases. The genetic link, described in the Sept...cine, was a collaborative effort led by Peter K.,G...bert S. Boas Center for,Genomics & Human Genetics....
...gthened with Clinical Trials Services and...and ATLANTA, Sept. 6 Image Solutions,Inc. (ISI) a...h,Biostatistics, Inc. (ZBI). With the Life Science...bmissions, the acquisition further strengthens,ISI...(CDISC) capabilities,the FDA-supported standard fo...
Other Medicine Technology:New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments 2New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments 3New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments 4Image Solutions, Inc. Acquires Zurich Biostatistics, Inc. 2Image Solutions, Inc. Acquires Zurich Biostatistics, Inc. 3
(Date:11/30/2009)... , Study Uses Tent To Simulate ..., Nov. 30 Distance runn...els are known to improve their performance during ...failure patients, who suffer from fatigue, improve...ike, high-altitude simulator? ,, That is the qu...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Of the m...ho are living with HIV/AIDS, nearly half are Afric...s in Washington, D.C. have surpassed the threshold...women account for more than 90 percent of all wome... On Tuesday, December 1 at 6:00 p.m.*, World AIDS ...
(Date:11/30/2009)...a tiny period of time between the registration of ...conscious recognition of it ― between the ti... an apple. Our minds lag behind our eyes, but by h... the world around us? , Some estimates say the...y 500 milliseconds. A new study by Tel Aviv Univer...
(Date:11/30/2009)... Keynote speaker & Author Dr. Te... Corpus Christi, TX (Vocus) No...Conference is set to be held in Corpus Christi fr... 5, 2009 at the American Bank Center., , , , ,The...cted to make a nearly $300,000 economic impact on ...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Reportlin...t is available in its catalogue: ,, Key Player...ging strategies in ingredients, pharma, food and d.../Key-Players-and-Innovative-Start-Ups-in-Nutraceut...od-and-drinks.html ,, Nutraceuticals are bioac...
Breaking Medicine News(10 mins):Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 3Health News:Now you see it, now you know you see it 2Health News:18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6
...D, UCLA Orthopedic Hospital, has been chosen as th...by the Journal of Alzheimers Disease in recognitio...d-beta and inflammation: Two faces of innate immun...e journal select an outstanding article from the p...
...e World Health Organization, nearly three-quarters...irus (HIV)-infected people are living in Sub-Sahar...infected in 2006 caught the virus in this part of ...fected. In contrast to what is observed in other r...
...alif., April 28 IPC The,Hospitalist Company, Inc....oup practice company, announced today that Adam D....present on Tuesday, May 6, 2008 at the,33rd Annual... Event: Deutsche Bank Health Care Conference Dat...
... Crystal Research Associates, LLC,announced today...rview(R),(EIO(R)) on Advaxis, Inc. (OTC Bulletin B...at http://www.crystalra.com ., Advaxis, Inc. ("A... responses against cancer as well as infectious,an...
...6-month Research Project Establishes Effects of Pu...y and Mind, GREENVILLE, N.C. and SEATTLE, April 2...tion and Leisure Studies today revealed,the result...s. The three puzzle and word games used in the stu...
...rweight as they conceive, raising complication ris...lthDay News) -- The number of women starting their...ubled since 1999, but rates of gestational diabete...r of teenagers who had diabetes before birth jumpe...
Other Medicine News:Health News:Milan Fiala, MD, receives 2008 Alzheimer Award 2Health News:Involving partners of pregnant women in Africa to improve AIDS prevention 2Health News:Involving partners of pregnant women in Africa to improve AIDS prevention 3Health News:IPC The Hospitalist Company, Inc. to Present at the 33rd Annual Deutsche Bank Health Care Conference 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Advaxis, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Advaxis, Inc. 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 2Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 4Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 5Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 6Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 7Health News:Pre-Pregnancy Diabetes Rates Have Doubled 2Health News:Pre-Pregnancy Diabetes Rates Have Doubled 3
Motion Graphic Display
72 Frame Eyewear Tower - Silver
...S display system provides maximum impact for the m...ue approach to displaying frames allows your retai...ealing, flexible and eye-catching displays. The pr...re motivated. Removable holders. Variable number o...
Hexagonal Revolving Tower Case
Medicine Products: